Finance

Beta
Lists
RNR:NYSE
Renaissancere Holdings Ltd
$280.35
-1.85%
(-5.28) 1D
$279.92
-0.15% (-0.43)
After hours
Closed: May 29, 4:00:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RNR...
Open
$284.62
High
$285.56
Low
$279.35
Mkt. cap
11.95B
Avg. vol.
374.31K
Volume
407.05K
Dividend
0.58%
Quarterly dividend
$0.41
Ex-dividend date
Jun 15, 2026
P/E ratio
4.68
52-wk high
$318.20
52-wk low
$231.17
EPS
$59.92
Beta
0.21
Shares outstanding
42.63M
No. of employees
1K
Open
$284.62
High
$285.56
Low
$279.35
Mkt. cap
11.95B
Avg. vol.
374.31K
Volume
407.05K
Dividend
0.58%
Quarterly dividend
$0.41
Ex-dividend date
Jun 15, 2026
P/E ratio
4.68
52-wk high
$318.20
52-wk low
$231.17
EPS
$59.92
Beta
0.21
Shares outstanding
42.63M
No. of employees
1K
News stories
From sources across the web
Profile
RenaissanceRe Holdings Ltd is a Bermudian provider of reinsurance, insurance and other related business services. The company operates in reinsurance, insurance and ventures. Reinsurance includes Renaissance Reinsurance Ltd., DaVinci Reinsurance Ltd., Top Layer Reinsurance Ltd., RenaissanceRe Europe AG, RenaissanceRe Syndicate 1458, and RenaissanceRe Specialty U.S. Ltd. The insurance segment includes RenaissanceRe Syndicate 1458. Ventures include RenaissanceRe Ventures Ltd. and Renaissance Underwriting Managers, Ltd. In 2013, the company's annual revenue was 405,209,000 dollars. Wikipedia
About Renaissancere Holdings Ltd
CEOKevin Odonnell
Employees1.04K
FoundedJun 1993
Headquarters-
SectorInsurance
Websiterenre.com
Last report
Apr 29, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$13.75 / $11.22
+22.50%beat
Revenue / Est. (USD)
2.20B / 2.96B
-25.44%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.20B
3.20B
2.99B
2.20B
Cost of goods sold
1.68B
1.54B
1.55B
1.51B
Cost of revenue
1.68B
1.54B
1.55B
1.51B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
147.52M
148.49M
130.88M
108.50M
Operating expense
147.52M
148.49M
130.88M
108.50M
Total operating expenses
1.83B
1.69B
1.68B
1.61B
Operating income
1.37B
1.51B
1.31B
589.62M
Other non operating income
-
-
-
-
EBT including unusual items
1.34B
1.48B
1.26B
548.81M
EBT excluding unusual items
1.34B
1.48B
1.26B
548.81M
Income tax expense
176.87M
148.86M
116.13M
32.98M
Effective tax rate
13.19%
10.05%
9.19%
6.01%
Other operating expenses
-
-
-
-
Net income
835.35M
916.51M
760.48M
293.38M
Net profit margin
26.12%
28.66%
25.45%
13.31%
Earnings per share
12.29
15.62
13.34
13.75
Interest and investment income
-
-
-
-
Interest expense
-31.79M
-30.58M
-31.39M
-31.79M
Net interest expenses
-31.79M
-30.58M
-31.39M
-31.79M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.37B
1.51B
1.37B
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer